Shiwei Jin

Four-year follow-up of LCAR-B38M in relapsed or refractory multiple myeloma: a phase 1, single-arm, open-label, multicenter study in China (LEGEND-2)

Wanhong Zhao, Baiyan Wang, Lijuan Chen et al. · Journal of Hematology & Oncology · 2022 · 139 citations · Full text

Neutrophil activation and clonal CAR-T re-expansion underpinning cytokine release syndrome during ciltacabtagene autoleucel therapy in multiple myeloma

Shuangshuang Yang, Jie Xu, Yuting Dai et al. · Nature Communications · 2024 · 40 citations · Full text

PD-1 downregulation enhances CAR-T cell antitumor efficiency by preserving a cell memory phenotype and reducing exhaustion

Wanyan Ouyang, Shiwei Jin, Nan‐Jie Xu et al. · Journal for ImmunoTherapy of Cancer · 2024 · 38 citations · Full text

Updated Phase 1 Results of a First-in-Human Open-Label Study of Lcar-B38M, a Structurally Differentiated Chimeric Antigen Receptor T (CAR-T) Cell Therapy Targeting B-Cell Maturation Antigen (Bcma)

Lijuan Chen, Jie Xu, Weijun Fu et al. · Blood · 2019 · 26 citations

AMP-activated protein kinase regulates autophagic protection against cisplatin-induced tissue injury in the kidney

Lai Wei, Wanqun Chen, Yan Zou et al. · Genetics and Molecular Research · 2015 · 22 citations · Full text

Autophagy Activation, Renal Pathology, Apoptosis +20